Form 4: RxSight, Inc. Director Robert Palmisano Acquires Shares

RxSight, Inc. reports that Director Robert J. Palmisano acquired 37,037 shares of common stock on June 17, 2026, as part of his compensation.

Summary

• Robert J. Palmisano, a Director at RxSight, Inc., acquired 37,037 shares of common stock on June 17, 2026.
• This acquisition is part of a restricted stock unit (RSU) award, where each RSU represents a contingent right to one share of common stock.
• The RSUs are subject to vesting conditions, with 100% vesting on the earlier of the one-year anniversary of the grant date (June 17, 2026) or the date of the next annual stockholder meeting.
• Following this transaction, Palmisano beneficially owns 78,076 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents standard director compensation and an insider acquiring shares, indicating confidence, but does not involve new strategic initiatives or significant financial performance data.

Positives

• Director Robert J. Palmisano's acquisition of shares indicates continued commitment and alignment with the company's performance.
• The vesting schedule for the RSUs incentivizes continued service as an Outside Director.

Future Outlook

The RSUs are set to vest on the earlier of the one-year anniversary of the grant date (June 17, 2026) or the date of the next annual stockholder meeting, contingent upon the Reporting Person's continued service as an Outside Director.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, particularly by directors, are often viewed positively by the market as they signal confidence in the company's future prospects. This type of transaction is standard for executive and director compensation in the biotechnology and medical device sectors.

Corporate Governance

Stakeholder Impact

• Shareholders: The acquisition by a director can be seen as a positive signal of confidence in the company's future, potentially influencing investor sentiment.
• Employees: Standard compensation practice for directors, reinforcing governance structures.
• Management: Demonstrates adherence to reporting requirements and compensation policies.

Next Steps

• Vesting of restricted stock units on the earlier of June 17, 2027, or the next annual stockholder meeting.
• Continued service by Robert J. Palmisano as an Outside Director.

Key Dates

Keywords

Form 4, SEC Filing, Insider Transaction, Stock Acquisition, Restricted Stock Units, Director Compensation, RxSight, Inc., RXST